NVAX

Novavax Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 1/10
Novavax sales and earnings growth
NVAX Growth
Good
  • Revenue Y/Y↓ -52.48%
  • EPS Y/Y↓ -117.82%
  • FCF Y/Y↑ 50.75%
Novavax gross and profit margin trends
NVAX Profitability
Low
  • Gross margin ↑ 85.00%
  • EPS margin↓ -14.70%
  • ROIC 5Y↓ 602.23%
Novavax net debt vs free cash flow
NVAX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.7
  • Interest coverage↓ -3.0

Novavax stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks